The use of medications approved for Alzheimer’s disease in autism spectrum disorder: a systematic review
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that affects 1 in 68 children in the United States. Even though it is a common disorder, only two medications (Risperidone and Aripiprazole) are approved by the U.S. Food and Drug Administration (FDA) to treat symptoms associated with...
Main Authors: | Daniel eRossignol, Richard Eugene Frye |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-08-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fped.2014.00087/full |
Similar Items
-
Treatments for Biomedical Abnormalities Associated with Autism Spectrum Disorder
by: Richard Eugene Frye, et al.
Published: (2014-06-01) -
Alzheimer disease and acetylcholinesterase inhibitors
by: Zahia Kabouche
Published: (2016-12-01) -
Molecular Targets of Bis (7)-Cognitin and Its Relevance in Neurological Disorders: A Systematic Review
by: Dalinda Isabel Sánchez-Vidaña, et al.
Published: (2019-05-01) -
Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer’s Disease: Are Irreversible Inhibitors the Future?
by: Donald E. Moss
Published: (2020-05-01) -
Some aspects of medication and non-medication treatment of Alzheimer's disease
by: O. V. Kotova, et al.
Published: (2015-12-01)